Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To investigate whether sildenafil (phosphodiesterase 5 inhibitor) induces migraine-like
headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic
brain injury (mTBI).